Padideh Kamali-Zare

What if a routine MRI could help predict your cognitive future?

Share This Talk

Have a suggestion for The Hive?
Submit a Nomination Today

About Padideh Kamali-Zare

Padideh Kamali-Zare, Ph.D. is the founding CEO of Darmiyan, Inc., an early stage biotech company that aims to revolutionize the way neurodegenerative diseases such as Alzheimer’s disease are detected. As the CEO of this rapidly growing San Francisco-based start up company, Padideh utilizes her creativity and expertise in biological physics and geometrical modeling to look for unconventional ways to solve problems and navigate the challenges faced by a young company. Padideh completed her doctoral studies at the Royal Institute of Technology, Stockholm, Sweden. In 2010 she moved to New York for her post-doctoral training in computational neuroscience, and then rose through the ranks to become an Adjunct Assistant Professor in the Department of Physiology & Neuroscience, prior to founding Darmiyan.

Find out more

About This Idea

Alzheimer’s is the most expensive disease in the United States. The worst part is, there's no cure. Padideh Kamali-Zare, CEO of Darmiyan, believes that early detection will revolutionize how we address Alzheimer’s disease, and her company has created a non-invasive virtual microscope to do just that. Watch her 2018 TEDMED Talk to learn about a new standard of brain health and monitoring that has the potential to save millions of lives.

Find out more

More Talks from the Hive

These talks are all a part of special session at TEDMED, called "Audacious" where we invite our innovators to take the stage and share the central idea they are working on, in short 2-minute talks. These talks are creatively grouped by 4 mini-segments, that serves as a creative link between each talk. To find out more visit The Hive page.